These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6488216)

  • 1. Transfer RNA breakdown products in the urine of asbestos workers.
    Fischbein A; Sharma OK; Solomon S; Buschman F; Apell G; Kohn M; Selikoff IJ; Bekesi JG; Borek E
    Cancer Detect Prev; 1984; 7(4):247-52. PubMed ID: 6488216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified nucleosides in asbestos workers at high risk of malignant disease: results of a preliminary study applying discriminant analysis.
    Solomon SJ; Fischbein A; Sharma OK; Borek E
    Br J Ind Med; 1985 Aug; 42(8):560-2. PubMed ID: 4016008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
    Fischbein A; Sharma OK; Selikoff IJ; Borek E
    Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.
    Amati M; Tomasetti M; Mariotti L; Tarquini LM; Valentino M; Santarelli L
    Mutat Res; 2008; 655(1-2):52-8. PubMed ID: 18638565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Asbestos fibre lung burden and exposure indices in asbestos-cement workers].
    Barbieri PG; Somigliana A; Lombardi S; Girelli R; Benvenuti A
    Med Lav; 2009; 100(1):21-8. PubMed ID: 19263869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Asbestos exposure and pleuropulmonary cancer].
    Bégin R
    Rev Mal Respir; 1999 Jan; 16 Suppl 2():S34-41. PubMed ID: 10028551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature.
    Ascoli V; Cavone D; Merler E; Barbieri PG; Romeo L; Nardi F; Musti M
    Am J Ind Med; 2007 May; 50(5):357-69. PubMed ID: 17407142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asbestos-related lung disease.
    O'Reilly KM; Mclaughlin AM; Beckett WS; Sime PJ
    Am Fam Physician; 2007 Mar; 75(5):683-8. PubMed ID: 17375514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular epidemiology case control study on pleural malignant mesothelioma.
    Bolognesi C; Martini F; Tognon M; Filiberti R; Neri M; Perrone E; Landini E; Canessa PA; Ivaldi GP; Betta P; Mutti L; Puntoni R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1741-6. PubMed ID: 16030111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exposure to asbestos and levels of selected tumor biomarkers].
    Krajewska B; Lutz W; Piłacik B
    Med Pr; 1996; 47(2):89-96. PubMed ID: 8657007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS.
    Fischbein A; Sharma OK; Valciukas JA; Bekesi JG; Buschman F; Apell G; Kohn M; Boesch RR; Teirstein A; Selikoff IJ
    Cancer Detect Prev; 1985; 8(1-2):271-7. PubMed ID: 4064047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological aspects of asbestos-related mesothelioma and knowledge of high risk for cancer.
    Lebovits AH; Chahinian AP; Gorzynski JG; Holland JC
    Cancer Detect Prev; 1981; 4(1-4):181-4. PubMed ID: 7349775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Hodgson JT; Darnton A
    Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of pleural mesothelioma in chrysotile asbestos textile workers.
    Peto J
    IARC Sci Publ; 1980; (30):703-11. PubMed ID: 7228327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
    Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
    Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters.
    Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK
    Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk after cessation of asbestos exposure: a cohort study of Italian asbestos cement workers.
    Magnani C; Ferrante D; Barone-Adesi F; Bertolotti M; Todesco A; Mirabelli D; Terracini B
    Occup Environ Med; 2008 Mar; 65(3):164-70. PubMed ID: 17704197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.